Noninvasive home telemonitoring: the Trans-European Network-Home-Care Management System.

2000;342:145–53. 3. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782–8. 4. The PEACE Investigators. Angiotensin-converting enzyme inhibitors in stable coronary artery disease. N Engl J Med 2004;351:2058–68. 5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981–97. 6. Nissen S, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary heart disease and normal blood pressure. The CAMELOT study: a randomized controlled trial. JAMA 2004;292:2217–26. 7. Williams B, Lacy PS, Thom S, et al., and the CAFE Investigators for the ASCOT Investigators. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes—The principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213–25.